United States v. Fred J. Greene

892 F.2d 453, 1989 U.S. App. LEXIS 19057, 1989 WL 152997
CourtCourt of Appeals for the Sixth Circuit
DecidedDecember 19, 1989
Docket89-5589
StatusPublished
Cited by21 cases

This text of 892 F.2d 453 (United States v. Fred J. Greene) is published on Counsel Stack Legal Research, covering Court of Appeals for the Sixth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Fred J. Greene, 892 F.2d 453, 1989 U.S. App. LEXIS 19057, 1989 WL 152997 (6th Cir. 1989).

Opinion

WELLFORD, Circuit Judge.

Defendant appeals the imposition of two concurrent sentences of eighteen months for unlawful distribution of marijuana. Because we find that the present classification of marijuana as a Schedule I substance is neither arbitrary nor irrational and that the possession of marijuana is not protected by the free exercise clause of the first amendment, we affirm the decision of the district court.

I.

On August 24, 1988, a federal grand jury sitting in Nashville returned an indictment against defendant Fred J. Greene charging him with seven counts of unlawful distribution of marijuana, a Schedule I Controlled Substance, in violation of 21 U.S.C. § 841(a)(1), and one count of unlawful use of a firearm in the commission of a drug trafficking felony in violation of 18 U.S.C. § 924(c)(1). Defendant filed a motion to dismiss the indictment and a memorandum in support of the motion alleging that the charges violated his rights to due process *455 and the free exercise of religion as the son of a Cherokee Indian mother.

Defendant called as an expert witness Dr. Jonathan J. Lipman, a Ph.D. in pharmacology and a research assistant at Vanderbilt University. Dr. Lipman testified that marijuana's active ingredient has a number of therapeutic uses including the prevention of nausea caused by cancer chemotherapy, the reduction of pressure inside the eye associated with glaucoma, the relaxation of muscle tissue, the dilation of bronchial tubes, and the reduction of insomnia.

Dr. Lipman further testified that marijuana use in human beings does not produce any physical dependency but may produce psychological dependence in people who use it continuously over a long period of time. Finally, Dr. Lipman was of the opinion that, although several questions about marijuana’s long-term use remain unresolved, no pharmacological basis exists for the inclusion of marijuana in Schedule I.

Defendant took the stand at the hearing to testify about his religious practices. 1 Defendant stated that his beliefs combine elements of the Native American religion with certain teachings from the Bible which he interpreted to promote the use of marijuana. Defendant admitted that he smoked and shared marijuana with other people “in communication with the Great Spirit,” and that he sold marijuana to promote his musical talent which is a gift of God.

At the time of arrest, police found $18,-000.00 in cash and two loaded firearms at defendant’s home. At the hearing, defendant testified that the money was for the promotion of his music and the guns were for his protection. Defendant admitted, however, that bagging the four kilograms of marijuana in his home into three hundred eighty-six (386) small bags was not a religious experience; only “partaking” of the drug was a religious experience. Defendant also admitted that as many as one hundred (100) to one hundred fifty (150) people came to his house each day to obtain marijuana.

The district court denied defendant’s motion to dismiss. Defendant then pled guilty to two counts of unlawful distribution of marijuana, reserving for appeal under Rule 11(a)(2) the freedom of religion and due process questions raised in his motion to dismiss.

II.

Defendant contends that the indictment should be dismissed because the classification of marijuana as a Schedule I controlled substance under the Federal Controlled Substances Act (“Act”), 21 U.S.C. §§ 841-904, and the imposition of penalties for its use, possession, or distribution, are irrational and arbitrary, thus violating the due process mandates of the fifth amendment. Basing his conclusions on medical evidence and the testimony of Dr. Lipman, an expert in pharmacology, and various articles dealing with its therapeutic use, defendant argues that marijuana, on pharmacological grounds, does not satisfy the three statutory criteria necessary for inclusion in Schedule I: (a) high potential for abuse; (b) no currently accepted medical use; and (c) lack of accepted safety for use of the drug under medical supervision. 21 U.S.C. § 812(b)(1). Defendant emphasizes that the placement of marijuana in Schedule I, when compared to the absence in the Schedules of more dangerous substances such as alcohol and nicotine, is particularly indicative of the irrational and arbitrary nature of the Schedules.

Other courts have considered this very issue in United States v. Fry, 787 F.2d 903 (4th Cir.), cert. denied, 479 U.S. 861, 107 S.Ct. 209, 93 L.Ed.2d 139 (1986), United States v. Fogarty, 692 F.2d 542 (8th Cir.1982), ce rt. denied, 460 U.S. 1040, 103 S.Ct. 1434, 75 L.Ed.2d 792 (1983), and United States v. Middleton, 690 F.2d 820, 823 (11th Cir.1982), cert. denied, 460 U.S. 1051, 103 S.Ct. 1497, 75 L.Ed.2d 929 (1983). Emphasizing that the judiciary may not sit as a “superlegislature” in reviewing legisla *456 tive policy determinations that do not affect fundamental rights, each court concluded that the present classification is not arbitrary or irrational. Fry, 787 F.2d at 905 (citing New Orleans v. Dukes, 427 U.S. 297, 303, 96 S.Ct. 2513, 2516, 49 L.Ed.2d 511 (1976) (per curiam)); Fogarty, 692 F.2d at 547 (citing Marshall v. United States, 414 U.S. 417, 427, 94 S.Ct. 700, 706, 38 L.Ed.2d 618 (1974), for the proposition that “judicial self-restraint is especially appropriate where as here the challenged classification entails legislative judgments on a whole host of controversial medical, scientific, and social issues.” Id.); Middleton, 690 F.2d at 824 (citing United States v. Kiffer, 477 F.2d 349 (2d Cir.), cert. denied, 414 U.S. 831, 94 S.Ct. 62, 165, 38 L.Ed.2d 65 (1973), for the proposition that “[t]he determination of whether new evidence regarding either the medical use of marijuana or the drug’s potential for abuse should result in a reclassification of marijuana is a matter for legislative or administrative, not judicial, judgment.” Id. at 823).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Blomquist
361 F. Supp. 3d 744 (W.D. Michigan, 2019)
United States v. Pickard
100 F. Supp. 3d 981 (E.D. California, 2015)
Storm-Eggink v. Gottfried
409 F. App'x 426 (Second Circuit, 2011)
Hutchinson v. Maine
641 F. Supp. 2d 40 (D. Maine, 2009)
United States v. Smith
46 F. App'x 247 (Sixth Circuit, 2002)
O Centro Espirita Beneficiente Uniao Do Vegetal v. Ashcroft
282 F. Supp. 2d 1236 (D. New Mexico, 2002)
Seeley v. State
940 P.2d 604 (Washington Supreme Court, 1997)
United States v. Thomas F. Brown
72 F.3d 134 (Eighth Circuit, 1995)
Opinion No.
Arkansas Attorney General Reports, 1994
United States v. Stephen Moralez
986 F.2d 1430 (Tenth Circuit, 1992)
Fulkerson v. City of Lancaster
801 F. Supp. 1476 (E.D. Pennsylvania, 1992)
United States v. Fred J. Greene
956 F.2d 270 (Sixth Circuit, 1992)
United States v. James Richard Burton
894 F.2d 188 (Sixth Circuit, 1990)

Cite This Page — Counsel Stack

Bluebook (online)
892 F.2d 453, 1989 U.S. App. LEXIS 19057, 1989 WL 152997, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-fred-j-greene-ca6-1989.